LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis

Conclusions: NEAT1/miR-149-5p/AKT1 pathway-based therapy might be a potential clinical application for HCC patients.

Source: The Saudi Journal of Gastroenterology - July 28, 2020 Category: Gastroenterology Authors: Yuexiang Niu Gongen Tang Xiuli Wu Chaoyu Wu Source Type: research